Developing Palatable Pediatric Formulations
Developing Palatable Pediatric Formulations. This webinar explores how you can leverage taste masking, modelling & simulation, clinical PK and taste assessment studies to achieve program success.
Thermal rearrangement – Flow Chemistry_Case Study
Quotient Sciences seeking to improve the yield and purity of a US Biotech API intermediate using flow chemistry
API Development Case Study
Rapid development of a scalable route towards an analogue of a new drug substance, with definition of an optimal salt form for formulation
Biochemical Assay Optimization, Validation & Application Case Study
UK specialty-pharma company in need of biochemical assay for their regulatory non-clinical safety study
Stable Isotope Labelling Case Study
Multiple, biotechnology and large-pharma companies needing isotope labelling support for their ADME/hAME studies
Radiosynthesis via chemically unstable intermediate Case Study
US biopharmaceutical company seeking to improve stability of their chemically unstable API intermediate for radiochemical trials
Analytical and Microbiological support Case Study
UK Clinical Research Unit (CRU), developing intravenous (IV) products in need of analytical & microbiological support
Analysis of Insulin Analogues Case Study
European biotech company developing an NCE to fulfil an unmet patient need, required insulin analogue analysis to gain regulatory approval
Drug Substance Salt Selection Case Study
US Biopharmaceutical seeking drug substanceand salt screen selection for their molecule.
Global Clinical Trial Supplies
Quotient can ease the headache of global product supply logistics and accelerate your proof-of-concept timeline. We’ll develop and manufacture your drug product, and then seamlessly integrate into a flexible packaging, labelling & distribution strategy, tailored to your clinical trial.
The Integration of Drug Substance and Drug Product
This webinar will highlight how a fully integrated program can speed up transition from candidate selection to proof of concept and shorten the pathway to clinical development.
Application of Translational Pharmaceutics in Accelerating the Development of MR Dosage Forms
Poster presentation at NERDG 2021 Annual Meeting. In this poster we demonstrate an optimized approach to developing oral modified-release (MR) dosage forms using the Translational Pharmaceutics platform. This approach uses emerging human data to inform adjustment of formulation composition in an adaptive clinical study.